Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Fall;5(4):213-8.

Bone mineral density loss in postmenopausal onset rheumatoid arthritis is not greater than premenopausal onset disease

Affiliations

Bone mineral density loss in postmenopausal onset rheumatoid arthritis is not greater than premenopausal onset disease

Behzad Heidari et al. Caspian J Intern Med. 2014 Fall.

Abstract

Background: Postmenopausal onset rheumatoid arthritis (post-RA) is expected to have greater bone mineral density (BMD) loss than premenopauasal onset (pre-RA) due to estrogen deficiency and aging. This study aimed to compare the BMD status of the two RA groups with age-matched non-RA controls.

Methods: The patients with RA on follow-up examination were stratified according to age of onset. Femoral neck and lumbar spine BMD (FN-BMD and LS-BMD) were assessed by DXA method. The patients of the two groups were compared with non-RA controls in regard to BMD gr/cm(2) and the risk of osteoporosis (OP).

Results: Forty-eight post-RA and 94 pre-RA were compared with 31 and 57 age-matched controls. FN-BMD gr/cm(2) and LS-BMD gr/cm(2) in both groups of RA was significantly lower than the controls (P=0.001 for all). In post-RA, FN-BMDgr/cm(2) was 16% lower than controls versus 21% in pre-RA, whereas, LS-BMD reductions were 5% and 12%, respectively (P=NS). FN-OP was observed in 32(68%) and 9 (29%) post-RA and controls (P=0.001) versus 29 (30.8%) and 4 (7%) pre-RA and controls, respectively (P=0.001). Corresponding percentages for LS-OP in post-RA and controls were (37.5% vs 35.5%, P=0.52) and in pre-RA and controls were (21.3% vs 3.5%, P=0.002), respectively. Risk of osteoporosis at either measurement sites of FN or LS in post-RA increased by the adjusted odds of 1.54(95% CI, 0.60-3.9, P=0.36) and in pre-RA by the adjusted odds of 5 (95% CI, 1.78-14.5, P=0.002), respectively.

Conclusion: These findings indicate that BMD loss in post-RA is not greater than pre-RA as expected. It is possible that estrogen deficiency by modulating immunologic reactions compensates the negative effects of estrogen deprivation on bone mass in post-RA patients.

Keywords: Age of onset; Bone mineral density; Osteoporosis; Postmenopausal; Premenopausal; Rheumatoid arthritis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Momohara S, Okamoto H, Yago T, et al. The study of bone mineral density and bone turnover markers in postmenopausal women with active rheumatoid arthritis. Mod Rheumatol . 2005;15:410–4. - PubMed
    1. Heidari B. Rheumatoid arthritis: Early diagnosis and treatment outcomes. Caspian J Intern Med. 2011;2:161–70. - PMC - PubMed
    1. Heidari B, Hassanjani Roushan MR. Rheumatoid arthritis and osteoporosis. Caspian J Intern Med. 2012;3:445–6. - PMC - PubMed
    1. Heidari B. Undifferentiated arthritis, predictive factors of persistent arthritis and treatment decision. Caspian J Intern Med. 2010;1:79–88.
    1. Heidari B, Heidari P, Tayebi ME. The value of changes in CRP and ESR for predicting treatment response in rheumatoid arthritis. APLAR J Rheumatol. 2007;10:23–8.

LinkOut - more resources